Comparing Cisplatin Dosing Schedules in Concurrent Chemoradiotherapy for Locally Advanced Head-and-Neck Cancer: A Comprehensive Review of Weekly Versus 3-Weekly Regimens

Objective: There are approximately 900,000 new cases of head-and-neck cancer (HNC) annually, with a significant proportion presenting as locally advanced head-and-neck cancer (LA-HNC). Cisplatin-based concurrent chemoradiotherapy (CCRT) has become widely accepted, particularly for patients deemed in...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Oscar Chi-Yu Yang, Nai-Wen Su, Yi-Shing Leu, Yi-Fang Chang
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wolters Kluwer Medknow Publications 2024-12-01
Ráidu:	Journal of Cancer Research and Practice
Fáttát:	chemotherapy cisplatin locally advanced head-and-neck cancer medical oncology therapeutic uses
Liŋkkat:	https://journals.lww.com/10.4103/ejcrp.eJCRP-D-24-00010
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!